Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for AstraZeneca plc > News item |
AstraZeneca initiated by Leerink Swann at outperform
AstraZeneca plc coverage was initiated by Leerink Swann & Co. with an outperform rating. London-based AstraZeneca is one of the world's leading pharmaceutical companies with a broad portfolio of medicines, including Nexium for gastrointestinal disease and Crestor for high cholesterol, and is working on treatments for cancer, cardiovascular, infection and neuroscience and respiratory problems. In the United States, AstraZeneca shares Wednesday slipped 7 cents, or 0.17%, to $41.91 on volume of 311,200 shares versus the three-month running average of 815,688.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.